House Energy and Commerce/Oversight Subcommittee
This article was originally published in The Gray Sheet
Executive Summary
Staffer Claudia Beville is leaving the Hill in early July and will be replaced by Mary Murray, a staffer in FDA's Office of Investigations. Beville reportedly has no immediate plans to take another job. Beville's tenure at the subcommittee included investigations into FDA's response to Bjork-Shiley heart valve failures in 1990 and into the agency's device good manufacturing practices and pre-market review programs in 1992. Beville authored a June 1993 subcommittee report on FDA's Center for Devices and Radiological Health entitled "Less Than the Sum of Its Parts" ("The Gray Sheet" June 7, 1993, p. 3)
You may also be interested in...
Former CDRH Director Put Problem Solving Before Data Monitoring
[Editor's Note: To mark the FDA centennial and the 30-year anniversary of the Medical Device Amendments to the Food, Drug & Cosmetic Act, "The Gray Sheet" is conducting a series of interviews looking back at the history of device regulation. Recently we sat down with John Villforth, who served as CDRH Director from 1982-1990.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”